Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

514 indexed citations

Abstract

loading...

About

This paper, published in 1992, received 514 indexed citations. Written by Rainy Umbas, Jack A. Schalken, Herbert F.M. Karthaus, H. Ewout Schaafsma, F M Debruyne and William B. Isaacs covering the research area of Molecular Biology. It is primarily cited by scholars working on Molecular Biology (351 citations), Pulmonary and Respiratory Medicine (188 citations) and Oncology (127 citations). Published in PubMed.

In The Last Decade

doi.org/w85610589 →

Countries where authors are citing Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

Specialization
Citations

This map shows the geographic impact of Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. more than expected).

Fields of papers citing Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer..

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w85610589.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026